Ciprofloxacin-OVA

Ciprofloxacin-OVA is a conjugate of Ciprofloxacin (HY-B0356) and Ovalbumin (OVA) . By conjugating the antigen with protein adjuvants, the production of antigen-specific antibodies in vaccine models can be enhanced. The conjugate does not affect protein folding or disrupt the primary epitopes, and it can enhance cross-presentation and the generation of antigen-specific T cells[1].

Product Specifications

UNSPSC

12352100

Target

Biochemical Assay Reagents

Related Pathways

Others

Field of Research

Inflammation/Immunology

Smiles

[Ciprofloxacin-OVA]

References & Citations

[1]Tsai WC, et, al. Ciprofloxacin-mediated cell proliferation inhibition and G2/M cell cycle arrest in rat tendon cells. Arthritis Rheum. 2008 Jun;58 (6) :1657-63.